Header Logo

Connection

Mary Fidler to Biopsy

This is a "connection" page, showing publications Mary Fidler has written about Biopsy.
Connection Strength

0.242
  1. De novo pauci-immune glomerulonephritis in renal allografts. Mod Pathol. 2020 03; 33(3):440-447.
    View in: PubMed
    Score: 0.039
  2. The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry. Kidney Int. 2019 10; 96(4):1005-1009.
    View in: PubMed
    Score: 0.038
  3. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. Kidney Int. 2018 07; 94(1):159-169.
    View in: PubMed
    Score: 0.035
  4. Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Kidney Int. 2015 Oct; 88(4):867-73.
    View in: PubMed
    Score: 0.029
  5. Biopsy-proven acute interstitial nephritis, 1993-2011: a?case?series. Am J Kidney Dis. 2014 Oct; 64(4):558-66.
    View in: PubMed
    Score: 0.027
  6. Membranous nephropathy with crescents: a series of 19 cases. Am J Kidney Dis. 2014 Jul; 64(1):66-73.
    View in: PubMed
    Score: 0.027
  7. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int. 2012 Jul; 82(2):226-34.
    View in: PubMed
    Score: 0.023
  8. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol. 2012 Feb; 7(2):231-9.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.